For personal use only

Transcription

1 21 March 2014 The Manager Company Announcements Office Australian Stock Exchange Exchange Centre 20 Bridge Street SYDNEY NSW 2000 ELECTRONIC LODGEMENT Dear Sir or Madam, Notice of 2014 Annual General Meeting and Proxy Forms Please find attached copies of: the Notice of Meeting for IRESS 2014 Annual General Meeting; the shareholder proxy voting form; and the voting direction form to the Trustee of the IRESS Employee Share Plans. Yours sincerely, Peter Ferguson Company Secretary IRESS Limited A.B.N Corporate Office: Level 18, 385 Bourke Street Melbourne Vic Australia Tel: (03) Fax (03) Sydney Office: Suite 4, 14 Martin Place Sydney NSW Australia Tel: (02) Fax: (02)

2 Notice is hereby given that the Annual General Meeting of the members of IRESS Limited ABN ( the Company ) will be held at IRESS Melbourne office, located at Level 18, 385 Bourke Street, Melbourne, Victoria on Thursday 1st May 2014, at am. Business Accounts To receive and consider the full financial report (financial statements, notes and Directors' Declaration) for the year ended 31 December 2013, together with the consolidated accounts of the Company and its controlled entities in accordance with the Corporations Act 2001 and associated Directors and Auditor s Reports. Resolutions Election and re-election of Directors To consider and, if thought fit, to pass the following resolution as an ordinary resolution: 1. That Jenny Seabrook be re-elected as a Director of the Company. Information regarding the candidate can be found in the accompanying Explanatory Notes. Remuneration Report To consider and, if thought fit, to pass the following resolution as an ordinary resolution: 2. That the Remuneration Report (which is contained in the Directors Report) for the year ended 31 December 2013 be adopted. Note: the vote on this resolution is advisory only and does not bind the Directors or the Company. Grant of Deferred Share Rights and Performance Rights to the Managing Director and CEO To consider and, if thought fit, to pass the following resolutions as ordinary resolutions: 3(a). That, for the purpose of ASX Listing Rule and all other purposes, the grant of up to 58,000 Deferred Share Rights to the Managing Director and CEO, Mr Andrew Walsh, and the provision of ordinary shares on exercise of those Deferred Share Rights, under the IRESS Limited Employee Deferred Share Rights Plan (as described in the Explanatory Notes) be approved. 3(b). That, for the purpose of ASX Listing Rule and all other purposes, the grant of up to 152,000 Performance Rights to the Managing Director and CEO, Mr Andrew Walsh, and the provision of ordinary shares on exercise of those Performance Rights, under the IRESS Limited Employee Performance Rights Plan (as described in the Explanatory Notes) be approved. Full copies of the IRESS Limited Employee Deferred Share Plan rules and the IRESS Limited Employee Performance Rights Plan rules are available upon request from the Company Secretary or from the Company s website at: Information regarding the resolutions may be found in the accompanying Explanatory Notes, which form part of this Notice of Meeting. Information for shareholders Entitlement to attend and vote All shareholders are entitled to attend the Annual General Meeting. For the purposes of voting at the meeting, shareholders will be taken to be those persons recorded on the Company s register of members at 7.00pm Page 1 of 11

3 (Melbourne time) on Tuesday 29 April With respect to joint shareholders, all holders may attend the meeting, but only one holder may vote at the meeting in respect of the relevant shares (including by proxy). If multiple joint holders are present and vote in respect of the relevant shares, only the vote of the joint holder whose name appears first in the register in respect of the relevant shares is counted. A corporate shareholder may appoint one or more persons to act as its representative(s), but only one representative is entitled to exercise the corporate shareholder s powers at one time. The Company will require the representative to provide appropriate evidence of the appointment. Appointment of proxies A shareholder entitled to attend and vote at the meeting may appoint: a) a person; or b) if the shareholder is entitled to cast two or more votes at the meeting, two persons, as the shareholder s proxy or proxies to attend and vote for the shareholder at the meeting by using the proxy form. If the shareholder appoints two proxies and the instrument does not specify the proportion or number of the shareholder s votes, each proxy may exercise half of the votes. A proxy need not be a shareholder, and may be an individual or a body corporate. A body corporate appointed as a proxy will need to ensure that it appoints an individual as its corporate representative to exercise its powers at the meeting. The corporate representative will be required to provide appropriate evidence of the appointment prior to the commencement of the meeting. The Company must receive at least 48 hours before the meeting (being no later than 11:30am (Melbourne time) on Tuesday 29 April 2014): a) the proxy s appointment; and b) if signed by the appointor s attorney, the authority under which the appointment was signed or a certified copy of the authority. Voting by proxies Shareholders should consider directing their proxy as to how to vote on each resolution by crossing a For or Against box when completing their proxy form to ensure that their proxy is permitted to vote on their behalf in accordance with their instructions. Pursuant to the Corporations Act 2001 (Cth), if the appointment of a proxy specifies the way the proxy is to vote on a particular resolution: the proxy is not required to vote on a show of hands, but if the proxy does so, the proxy must vote as directed (subject to any applicable voting exclusions); if the proxy has two or more appointments that specify different ways to vote on the resolutions, the proxy must not vote on a show of hands; if the proxy is not the Chairman, the proxy need not vote on a poll but if the proxy does so, the proxy must vote as directed (subject to any applicable voting restrictions); and if the proxy is the Chairman, the proxy must vote on a poll and must vote as directed. Default to Chairman If: a poll has been called on a resolution; and a shareholder has appointed a proxy other than the Chairman and the appointment of the proxy specifies the way the proxy is vote on the resolution; and the shareholder s proxy is either: not recorded as attending the Annual General Meeting; or Page 2 of 11

4 attends the Annual General Meeting but does not vote on the resolution, then the Chairman of the Annual General Meeting, will before voting on the resolution closes, be taken to have been appointed as the proxy for that shareholder for the purposes of voting on that resolution. In these circumstances, the Chairman must vote in accordance with the written direction of that shareholder. Proxy by post or facsimile The proxy s appointment and, if applicable, the authority appointing an attorney, may be sent by post or fax to the Company s Share Registry at the address or fax number set out below: IRESS Limited C/- Link Market Services Limited Locked Bag A14 Sydney South NSW 1235 Fax (02) Online proxy Shareholders may submit their proxy online by visiting To use this option, shareholders will need their Security holder Reference Number (SRN) or Holder Identification Number (HIN), surname or Company name and postcode. Shareholders will be taken to have signed the proxy form if it is lodged in accordance with the instructions on the website. A proxy appointed under Power of Attorney or similar authority may be lodged electronically in the same manner. The Registry will keep a record of the authority under which the appointment was made. The online proxy facility may not be suitable for some shareholders, including those who wish to appoint two proxies with different voting instructions. By Order of the Board Peter Ferguson SECRETARY Melbourne, 21 March 2014 Page 3 of 11

5 Explanatory Notes Resolution 1 Re-election of Jenny Seabrook Jenny Seabrook is a Non-Executive Director of the Company and was appointed as a Director on 20 August Jenny has been Lead Independent Director since May 2010, Chair of the Nomination and Remuneration Committee since May 2011 and is a member of the Audit Committee. Jenny holds a Bachelor of Commerce degree (B.Com), is a chartered accountant with employment experience in the capital markets and mergers and acquisitions sectors of the financial services industry and has extensive public company board experience. Her employment history includes Touche Ross, Hong Kong Bank, Hartleys, and Gresham. Jenny is a special advisor to Gresham Partners Limited, a non-executive director of Iluka Resources Limited, and the Export Finance and Insurance Corporation. She was a member of ASIC s external advisory group until November 2013 and a member of the Takeovers Panel from 2000 to Jenny s previous directorships include Alinta Gas, Amcor Limited, Australia Post, BankWest, Edith Cowan University, MG Kailis, Princess Margaret and King Edward Hospital, West Australian Newspapers Holdings Limited, and Western Power. Directors' Recommendation The Board (other than Ms Seabrook because of her interest) recommends that shareholders vote in favour of Resolution 1. Resolution 2 - Remuneration Report The Remuneration Report forms part of the Directors Report, and is included in the Company s Annual Report for the year ended 31 December The Annual Report is available on the Company s website at In accordance with the Corporations Act 2001, the Company is seeking the adoption of the Remuneration Report by shareholders at this Annual General Meeting. The Remuneration Report: explains the Company s remuneration policy as well as its relationship with and link to the Company s performance; contains the remuneration details of the Directors and other key management personnel (KMP) of the Company; and explains the incentive arrangements in place for the Company s employees. The Remuneration Report also sets out details of the key changes made to the Company s remuneration policy and remuneration structure during 2013, a number of which were in response to investor feedback received at last year s Annual General Meeting. The key changes are summarised in the table below. The table also includes a brief statement of the three types of equity instruments currently on issue and the associated incentive plans currently operated by the Company. IRESS Incentive Plans The Company currently has three types of equity instruments on issue and operates three associated plans, which are referred to below as follows: "Deferred Shares" issued under the IRESS Limited Employee Deferred Share Plan ("Deferred Share Plan"). "Deferred Share Rights" issued under the IRESS Limited Employee Deferred Rights Share Plan ("Deferred Share Rights Plan"). "Performance Rights" issued IRESS Limited Employee Performance Rights Plan ("Performance Rights Plan"). Page 4 of 11

6 Deferred Shares Rights to replace Deferred Shares Reclassification of Deferred Share Rights from 'LTI' to 'STI' Future STI awards Re-testing of Performance Rights and changes to the TSR hurdle In previous years, Deferred Shares and Deferred Share Rights have been granted to the CEO and key executives of the Company as part of their long term incentive (LTI) awards. A Deferred Share or Deferred Share Right is the right to own a share in the Company subject to the satisfaction of individual performance hurdles and ongoing employment at the time of vesting, which is generally 3 years from the date of grant. Deferred Shares carry an entitlement to receive dividends and voting rights in relation to the Deferred Shares during the vesting period. Investor feedback received at last year s Annual General Meeting suggested that the entitlement to receive dividends and voting rights on unvested incentives was outside market practice for executive incentive schemes. Deferred Share Rights are similar to Deferred Shares but do not carry an entitlement to receive dividends or voting rights during the vesting period. Accordingly, for future STI awards, the Company will grant Deferred Share Rights to the CEO and key executives as part of the STI component of their respective remuneration packages. There will be no further grants of Deferred Shares to the CEO or key executives, however, Deferred Shares will continue to form a part of the incentive arrangements for other employees. The terms of the previous grants of Deferred Shares have not been changed. Further details about those terms can be found in the Company s 2013 Remuneration Report which can be accessed at In conjunction with the above change, the Company has determined that the structure and features of Deferred Share Rights are similar to the deferred equity short term incentive (STI) arrangements commonly adopted by other ASX listed companies. For example, hurdles based on individual performance and continued service with the Company are more closely aligned with the features of an STI award rather than a market standard LTI award. Accordingly, Deferred Share Rights, previously described as LTIs, have been reclassified as deferred STIs to better reflect the nature of these grants. In previous years, the Company's STI awards comprised cash payments only. In light of evolving market practice among ASX listed companies and investor feedback received at last year s AGM, the Company is proposing to make future STI awards to the CEO and key executives through a mix of cash payments and Deferred Share Rights (as described above), with 35% provided as cash and 65% deferred through the provision of Deferred Share Rights. With the reclassification of Deferred Share Rights as an STI award, the Company's only LTI instrument comprises Performance Rights. In response to investor feedback received at last year s Annual General Meeting, the Performance Rights Plan has been amended to reduce the number of potential retests. In previous years, Performance Rights that did not vest on the measurement date were eligible for monthly retests over the six month period following the initial measurement date. For future grants, those six retests have been replaced with a single retest Page 5 of 11

7 which will occur six months after the initial measurement date. The Company s total shareholder return ( TSR ) performance relative to the TSR peer group as at the retest date must exceed performance as at the initial measurement date for any additional Performance Rights to vest on the retest date. For all future grants of Performance Rights that are subject to the TSR performance hurdle, the TSR performance of the Company relative to the TSR peer group will be assessed using the volume weighted average share prices for both the Company and each company in the TSR peer group over the 20 trading days before the start of the measurement period and the 20 trading days before the end of the measurement period. These changes reflect the Company s desire to align its executive remuneration structure with shareholder interests and evolving market practice for ASX listed companies. Directors' Recommendation The vote on the adoption of the Remuneration Report is advisory only. However, the board will take the outcome of the vote into consideration in future reviews of the remuneration policy for Directors and other KMP of the Company. The Board unanimously recommends that shareholders vote in favour of Resolution 2. Voting exclusion A vote must not be cast (in any capacity) on this resolution by or on behalf of a member of the Company s KMP whose remuneration details are included in the Remuneration Report, or a KMP s closely related party. A closely related party includes a spouse, dependant and certain other close family members of a KMP, as well as any companies controlled by a KMP. However, a vote may be cast by a KMP or a KMP s closely related party if they do so as a proxy and: the vote is not cast on behalf of a KMP or a KMP s closely related party; and the appointment of the proxy is in writing and specifies the way the proxy is to vote on this resolution; or the proxy is the Chairman of the meeting and the appointment of the Chairman of the meeting as proxy: does not specify the way the proxy is to vote on this resolution; and expressly authorises the Chairman of the meeting to exercise the proxy even if the resolution is connected directly or indirectly with the remuneration of the KMP. If you appoint the Chairman of the meeting as your proxy, and you do not direct your proxy how to vote on this resolution on the proxy form, you will be expressly authorising the Chairman of the meeting to exercise your proxy on this resolution. The Chairman of the meeting intends to vote undirected proxies in favour of this resolution. Resolutions 3(a) and 3(b) Grant of Deferred Share Rights and Performance Rights to the Managing Director and CEO Background The Board is seeking shareholder approval for a proposed grant of the following instruments in connection with Mr Walsh s short term incentive (STI) and long term incentive (LTI) arrangements for These awards should be considered in the context of the achievements of IRESS in 2013 which are detailed in the 2013 Annual Report. Significantly IRESS achieved better than expected financial performance in 2013 in Page 6 of 11

8 spite of the business conditions for financial market participants, which before the impact of the Avelo acquisition, was near neutral aggregate segment profit growth incorporating the strong growth of its wealth management division. Also in 2013, IRESS successfully completed its transformational acquisition of Avelo in the United Kingdom, integrated Avelo s operations with IRESS existing operations in the United Kingdom and reviewed and modified its management structure in light of the increased scale of operations. Instrument Quantum Grant Date Measurement (maximum) 1 Commencement date Term of measurement period Deferred Share Rights (STI) Performance Rights (LTI) Performance Rights (LTI) 58,000 7 May May years 76,000 7 May May years 76,000 7 May May years 1 Each Performance Right or Deferred Share Right will give Mr Walsh a right to acquire one ordinary share in the Company on vesting and exercise, subject to the satisfaction of the applicable conditions. The mix of Deferred Share Rights and Performance Rights above broadly mirrors the mix of instruments granted to other senior executives of the Company. Approvals sought Under ASX Listing Rule 10.14, shareholder approval is required for certain issues of securities to directors of the Company under an employee incentive scheme. Accordingly, shareholders are being asked to approve a grant of Deferred Share Rights and Performance Rights to the Managing Director and CEO, Mr Andrew Walsh. Key terms of grant The key terms of the grant of Deferred Share Rights and Performance Rights proposed to be made to Mr Walsh under the Deferred Share Rights Plan and the Performance Rights Plan are set out below. Further details about the Plans are included in the Remuneration Report which is contained in the Company s 2013 Annual Report. Maximum number The maximum number of Deferred Share Rights and Performance Rights that can be granted to Mr Walsh is set out in the table above. These have been determined using a number of factors including the IRESS share price in the period prior to release of Notice of Meeting. The actual number of Deferred Share Rights and Performance Rights granted may be less than the maximum number as Directors will consider the value of the Deferred Share Rights and Performance Rights grants at the time of grant (based on the prevailing market price). Estimated Total 2013 Remuneration The table below shows the estimated total value of remuneration for Mr Walsh for 2013, including the estimated accounting fair value of the Deferred Share Rights and Performance Rights, and compares this with his estimated total remuneration for The values are estimates because: 1) for 2013, the total value assumes the maximum number of Deferred Share Rights and Performance Rights are granted and values these on the estimated accounting fair value basis as at 21 March 2014 (the date of this Notice of Meeting). The actual number granted may be less and the value on the date of grant, vesting or exercise may be different; and Page 7 of 11

9 2) for both 2012 and 2013, the actual values may vary because the rights may not vest and the value of these rights may be different to their fair value as shown in this table Fixed Remuneration 1 January $805,000 $805,000 October Review adjustment $195,000 Nil A 31 December $1,000,000 $805,000 B Superannuation $25,000 $25,000 STI Date of grant C Cash STI $500,000 1 $310,000 Deferred Shares (2012)/ Deferred Share Rights (2013) 58,000 55,000 2 D Fair value estimate $450,000 3 $468,050 4 LTI Performance Rights 3 years measurement term commencing: 7 May 2014 (for 2012 grant) and 7 May 2015 (for 2013 grant) 76,000 65,000 2 E Fair value estimate $380,000 3 $326,950 4 Performance Rights 4 years measurement term commencing: 7 May 2013 (for 2012 grant) and 7 May 2014 (for 2013 grant) 76,000 65,000 2 F Fair value estimate $415,000 3 $309,400 4 Total remuneration A+B+C+D+E+F $2,770,000 $2,244,400 Note 1: Mr Walsh received an increased cash STI award in 2013 on expected award due to the Avelo transaction. Note 2: At the 2013 AGM approval was given for the award of up to 65,000 Deferred Shares and up to 160,000 Performance Rights (80, ,000) to Mr Walsh for his performance in Post the AGM Mr Walsh was awarded 55,000 Deferred Shares and 130,000 Performance Rights (65, ,000). Note 3: Fair value estimate at 21 March Note 4: Fair value estimate at grant date (7 May 2013). If shareholder approval is obtained, the Deferred Share Rights and Performance Rights will be granted within 12 months of the date of this meeting. Page 8 of 11

10 Price payable Specific terms Deferred Share Rights Specific terms Performance Rights The Deferred Share Rights and Performance Rights will be granted at no cost to Mr Walsh. If the applicable performance hurdle is met in respect of the Performance Rights (as described below), Mr Walsh must pay a nominal exercise price of $1.00 to exercise his Performance Rights and acquire the shares. This exercise price is payable irrespective of the number of Performance Rights exercised on that particular day. The same price applies to all other employees to whom Performance Rights are granted under the Performance Rights Plan. There is no exercise price payable in relation to the Deferred Share Rights. The number of Deferred Share Rights to be granted to Mr Walsh is based on his performance against annual objectives in the year ending 31 December The Deferred Shares Rights will become eligible to vest and convert into ordinary shares in the Company if Mr Walsh remains employed with the Company at the end of the three year measurement period and achieves acceptable individual performance as determined by the Board. Any Deferred Share Rights that do not vest at the end of the three year measurement period will lapse. The number of Performance Rights to be granted to Mr Walsh is based on his contribution in the year ended 31 December 2013 to the achievement of strategic objectives and the extent to which he could impact on these objectives and the results of the Company in the next 3 to 4 years. The Performance Rights will be granted in two tranches. The first tranche will have a four year performance measurement period commencing on the grant date, and the second tranche will have a three year performance measurement period commencing on the twelve month anniversary of the grant date. The Performance Rights are subject to a performance condition based on the Company s Total Shareholder Return ( TSR ) during a relevant measurement period as compared to the Total Shareholder Return for each company in a peer group of companies. The peer group of companies comprises the top 200 companies listed in the S&P/ASX200 companies (ranked by market capitalisation) after excluding mining companies and listed property trusts. A peer company must have been in the ASX/S&P 200 companies for the entire measurement period (i.e. new entrants and companies dropping out of the S&P/ASX200 companies are excluded). The Company s ranking within that group of companies at the end of the relevant measurement period determines the number of Performance Rights that become exercisable (if any) on the following basis: Performance ranking range Number of Performance Rights exercisable Below 50th percentile 50th percentile 51st percentile to 74th percentile 75th percentile or higher No Performance Rights exercisable 50% of the Performance Rights available to be exercised Performance Rights available to be exercised will be determined on a pro-rata basis between 50% and 100% depending on the Company s percentile performance ranking 100% of Performance Rights available to be exercised The TSR performance of the Company and each company in the peer group is assessed based on the volume weighted average share price of the Company and each of the companies in the peer group for the 20 trading days prior to both the measurement Page 9 of 11

11 Cessation of employment Change of control Dividend and voting rights Other required information ASX Listing Rules period commencement date and the measurement end date. Any Performance Rights that do not vest will be subject to one retest, occurring six months after the initial measurement date. The Performance Rights will then only be able to be exercised in accordance with their normal terms (i.e. subject to the same performance condition tested at the end of the retest period). Accordingly, Performance Rights will vest and be able to be exercised only to the extent the: TSR hurdle is satisfied at the retest date; and TSR performance of the Company at the end of the retest date exceeds the TSR performance of the Company as at the initial measurement date. Any Performance Rights that do not vest at the end of the initial measurement date or the retest date will lapse. Subject to applicable law relating to the provision of benefits, if Mr Walsh s employment with the Company ceases for any reason, he will retain all vested but unexercised Deferred Share Rights or Performance Rights, and these may only be exercised by Mr Walsh in accordance with their normal terms. Subject to applicable law relating to the provision of benefits, and unless the Board determines otherwise unvested Deferred Share Rights or Performance Rights will be treated as follows: 1. where Mr Walsh s employment ceases other than as a result of a Qualifying Reason as defined in the Plans 1, any unvested Deferred Share Rights or Performance Rights (as the case may be)will lapse; 2. where Mr Walsh s employment ceases as a result of a Qualifying Reason: if less than six months of the relevant measurement period has elapsed at the date of cessation of employment, all of the unvested Deferred Share Rights or Performance Rights held by Mr Walsh will lapse (as the case may be); if six months or more of the measurement period has elapsed at the date of cessation of employment, a pro-rata number of unvested Deferred Share Rights or Performance Rights (as the case may be) will lapse having regard to the portion of the measurement period that has elapsed as at the date of cessation and the total measurement period (excluding any retesting period). Any rights that do not lapse will then become eligible to vest and be able to be exercised in accordance with their normal terms. If certain change of control events occur in relation to the Company, the Board may determine in its absolute discretion to give participants in the Plans (including Mr Walsh) notice that their Deferred Share Rights and Performance Rights may vest and/or be exercised irrespective of whether the relevant performance conditions (if any) have been satisfied at that time. Mr Walsh will not be eligible to receive any dividends on the Deferred Share Rights or Performance Rights until the rights vest and shares are provided. The Deferred Share Rights or Performance Rights do not carry any voting rights. Mr Walsh is currently the only Director who is eligible to receive grants of Deferred Share Rights under the Deferred Share Rights Plan, or Performance Rights under the Performance Rights Plan. No other Deferred Shares, Deferred Share Rights or Performance Rights have been granted to directors under the Plans since the 2013 Annual General Meeting. No loan will be made available by the Company to Mr Walsh in connection with the grants of Deferred Share Rights or Performance Rights. 1 In the Plans, Qualifying Reason means (i) the death, total and permanent disability, retirement or redundancy of the holder as determined by the Board in its absolute discretion; (b) the holder ceasing to be employed by an entity within the Group as a result of an entity ceasing to be a member of the Group, or an entity in the Group selling a business it conducts other than to another entity in the Group; or (c) any other reason as determined by the Board in its absolute discretion. Page 10 of 11

12 Directors Recommendation The Non-Executive Directors have formed the view that Mr Walsh s remuneration package (which includes the proposed grant of Deferred Share Rights and Performance Rights) is reasonable, having regard to the circumstances of the Company and Mr Walsh s duties and responsibilities. The Board (other than Mr Walsh because of his interest) recommends that shareholders vote in favour of Resolutions 3(a) and 3(b). Voting exclusion The Company will disregard any vote cast on this resolution by Mr Walsh or his associates. Further, a vote must not be cast on this resolution by a KMP or a KMP s closely related party acting as a proxy if their appointment does not specify the way the proxy is to vote on this resolution. However, the Company will not disregard votes: by such persons as proxy for another person who is entitled to vote and the vote is cast in accordance with the directions on the proxy form; or if the vote is cast by the Chairman (who is a KMP) as a proxy for a person who is entitled to vote and the proxy appointment expressly authorises the Chairman to exercise the proxy even though this resolution is connected directly or indirectly with the remuneration of a member of the KMP of the Company. If you appoint the Chairman of the meeting as your proxy, and you do not direct your proxy how to vote on this resolution on the proxy form, you will be expressly authorising the Chairman of the meeting to exercise your proxy on this resolution. The Chairman of the meeting intends to vote undirected proxies in favour of this resolution. Page 11 of 11

13 IRESS Limited ABN ONLINE By mail: IRESS Limited C/- Link Market Services Limited Locked Bag A14 Sydney South NSW 1235 Australia LODGE YOUR VOTE By fax: All enquiries to: Telephone: Overseas: *X * X I/We being a member(s) of IRESS Limited and entitled to attend and vote hereby appoint: STEP 1 the Chairman of the Meeting (mark box) SHAREHOLDER PROXY FORM APPOINT A PROXY OR if you are NOT appointing the Chairman of the Meeting as your proxy, please write the name of the person or body corporate (excluding the registered shareholder) you are appointing as your proxy. I/we appoint the Chairman of the Meeting as an alternate proxy to the person named. If no person/body corporate is named, the Chairman of the Meeting, is appointed as my/our proxy and to vote for me/us on my/our behalf at the Annual General Meeting of the Company to be held at 11:30am on Thursday, 1 May 2014, at IRESS Melbourne office, Level 18, 385 Bourke Street, Melbourne, Victoria and at any adjournment or postponement of the meeting. I/we expressly authorise the Chairman of the Meeting to exercise my/our proxy even if the resolution is connected directly or indirectly with the remuneration of a member of the key management personnel. The Chairman of the Meeting intends to vote undirected proxies in favour of all items of business. Proxies will only be valid and accepted by the Company if they are signed and received no later than 48 hours before the meeting. Please read the voting instructions overleaf before marking any boxes with an X STEP 2 Resolution 1 Re-election of Jenny Seabrook as a Director Resolution 2 Adoption of the Remuneration Report (advisory only) VOTING DIRECTIONS For Against Abstain* Resolution 3a For Against Abstain* Approval of Deferred shares to be issued to the Managing Director Resolution 3b Approval of Performance Rights to be issued to the Managing Director * If you mark the Abstain box for a particular Item, you are directing your proxy not to vote on your behalf on a show of hands or on a poll and your votes will not be counted in computing the required majority on a poll. STEP 3 SIGNATURE OF SHAREHOLDERS THIS MUST BE COMPLETED Shareholder 1 (Individual) Joint Shareholder 2 (Individual) Joint Shareholder 3 (Individual) Sole Director and Sole Company Secretary Director/Company Secretary (Delete one) Director This form should be signed by the shareholder. If a joint holding, either shareholder may sign. If signed by the shareholder s attorney, the power of attorney must have been previously noted by the registry or a certified copy attached to this form. If executed by a company, the form must be executed in accordance with the company s constitution and the Corporations Act 2001 (Cth). IRE PRX401R *IRE PRX401*

14 HOW TO COMPLETE THIS PROXY FORM Your Name and Address This is your name and address as it appears on the Company s share register. If this information is incorrect, please make the correction on the form. Shareholders sponsored by a broker should advise their broker of any changes. Please note: you cannot change ownership of your shares using this form. Appointment of a Proxy If you wish to appoint the Chairman of the Meeting as your proxy, mark the box in Step 1. If the person you wish to appoint as your proxy is someone other than the Chairman of the Meeting please write the name of that person in Step 1. If you appoint someone other than the Chairman of the Meeting as your proxy, you will also be appointing the Chairman of the Meeting as your alternate proxy to act as your proxy in the event the named proxy does not attend the meeting. Votes on Items of Business Proxy Appointment You may direct your proxy how to vote by placing a mark in one of the boxes opposite each item of business. All your shares will be voted in accordance with such a direction unless you indicate only a portion of voting rights are to be voted on any item by inserting the percentage or number of shares you wish to vote in the appropriate box or boxes. If you do not mark any of the boxes on the items of business, your proxy may vote as he or she chooses. If you mark more than one box on an item your vote on that item will be invalid. Appointment of a Second Proxy You are entitled to appoint up to two persons as proxies to attend the meeting and vote on a poll. If you wish to appoint a second proxy, an additional Proxy Form may be obtained by telephoning the Company s share registry or you may copy this form and return them both together. The appointment of the Chairman of the Meeting as your alternate proxy also applies to the appointment of the second proxy. To appoint a second proxy you must: (a) on each of the first Proxy Form and the second Proxy Form state the percentage of your voting rights or number of shares applicable to that form. If the appointments do not specify the percentage or number of votes that each proxy may exercise, each proxy may exercise half your votes. Fractions of votes will be disregarded; and (b) return both forms together. Signing Instructions You must sign this form as follows in the spaces provided: Individual: where the holding is in one name, the holder must sign. Joint Holding: where the holding is in more than one name, either shareholder may sign. Power of Attorney: to sign under Power of Attorney, you must lodge the Power of Attorney with the registry. If you have not previously lodged this document for notation, please attach a certified photocopy of the Power of Attorney to this form when you return it. Companies: where the company has a Sole Director who is also the Sole Company Secretary, this form must be signed by that person. If the company (pursuant to section 204A of the Corporations Act 2001) does not have a Company Secretary, a Sole Director can also sign alone. Otherwise this form must be signed by a Director jointly with either another Director or a Company Secretary. Please indicate the office held by signing in the appropriate place. Corporate Representatives If a representative of the corporation is to attend the meeting the appropriate Certificate of Appointment of Corporate Representative should be produced prior to admission in accordance with the Notice of Meeting. A form of the certificate may be obtained from the Company s share registry. Lodgement of a Proxy Form This Proxy Form (and any Power of Attorney under which it is signed) must be received at an address given below by 11:30am on Tuesday, 29 April 2014, being not later than 48 hours before the commencement of the meeting. Any Proxy Form received after that time will not be valid for the scheduled meeting. Proxy Forms may be lodged using the reply paid envelope or: ONLINE Login to the Link website using the holding details as shown on the proxy form. Select Voting and follow the prompts to lodge your vote. To use the online lodgement facility, shareholders will need their Holder Identifier (Securityholder Reference Number (SRN) or Holder Identification Number (HIN) as shown on the front of the proxy form). by mail: IRESS Limited C/- Link Market Services Limited Locked Bag A14 Sydney South NSW 1235 Australia by fax: by hand: delivering it to Link Market Services Limited, 1A Homebush Bay Drive, Rhodes NSW 2138 or Level 12, 680 George Street, Sydney NSW If you would like to attend and vote at the Annual General Meeting, please bring this form with you. This will assist in registering your attendance.

15 ONLINE LODGE YOUR VOTE IRESS Limited ABN By mail: IRESS Limited C/- Link Market Services Limited Locked Bag A14 Sydney South NSW 1235 Australia By fax: All enquiries to: Telephone: Overseas: *X * X VOTING DIRECTION FORM STEP 1 DIRECTION TO THE TRUSTEE OF THE PLAN I, being a participant of the Direction to the Trustee of the Deferred Employee Share Plan direct the Trustee of the Plan to vote on my behalf in respect of any voting rights attaching to shares held for my benefit under the Plan at the Annual General Meeting of the Company to be held at 11:30am on Thursday, 1 May 2014 at IRESS Melbourne office, Level 18, 385 Bourke Street, Melbourne, Victoria and at any adjournment of that meeting. Forms will only be valid and accepted by the Company if they are signed and received no later than 11:30am on Monday, 28th April This form will only be used for the purpose of voting on the resolutions specified below. To direct the Trustee on how to vote on any resolution, please insert X in the appropriate box. In the absence of a direction by you, the Trustee has no direction and your votes will not be counted. STEP 2 Resolution 1 Re-election of Jenny Seabrook as a Director Resolution 2 Adoption of the Remuneration Report (advisory only) For Against Abstain* VOTING DIRECTIONS Resolution 3a Approval of Deferred shares to be issued to the Managing Director Resolution 3b Approval of Performance Rights to be issued to the Managing Director For Against Abstain* * If you mark the Abstain box for a particular Resolution, you are directing the Trustee not to vote on your behalf and your votes will not be counted in computing the required majority on a poll. STEP 3 Signature of Participant SIGNATURE OF PARTICIPANT THIS MUST BE COMPLETED IRE VDF401 *IRE VDF401*